These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11291643)

  • 1. [Reporting drug side effects in dermatology].
    Jonville-Béra AP
    Ann Dermatol Venereol; 2001 Jan; 128(1):58. PubMed ID: 11291643
    [No Abstract]   [Full Text] [Related]  

  • 2. [Topical tacrolimus in dermatology: what can one expect?].
    Lacour JP
    Ann Dermatol Venereol; 2001 Dec; 128(12):1291-4. PubMed ID: 11908129
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current regulations for reporting of side effects in The Netherlands after 1995].
    Broekmans AW; Lekkerkerker JF; de Koning GH; Vree PH
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1166-7. PubMed ID: 8692349
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of declarations of severe adverse effects from the publication of the decree dated 13 March 1995 about the organisation of pharmacovigilance].
    Lelouet H; Morin M; Trenque T; Bidault I; Castot A; Alexandre JM
    Therapie; 1996; 51(5):555-6. PubMed ID: 9138393
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reporting a side effect].
    Roos N; Vigan M
    Ann Dermatol Venereol; 2009 Oct; 136 Suppl 6():S381-5. PubMed ID: 19931702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biovigilance. (Decree no 2003-1206 of December 12, 2003].
    Villeneuve P
    Rev Infirm; 2004 Mar; (99):39-40. PubMed ID: 15124496
    [No Abstract]   [Full Text] [Related]  

  • 7. Toll-free number for reporting adverse events on labeling for human drug products. Interim final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jan; 73(2):402-4. PubMed ID: 18389912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canada proposes amendments to adverse drug reaction reporting.
    McMahon E; Reguly T
    Health Law Can; 2009 Oct; 30(1):9. PubMed ID: 19994551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interview -- drug legislation -- reporting unexpected adverse drug reactions].
    Ludwig WD
    Pneumologie; 2009 Sep; 63(9):479-80. PubMed ID: 19764017
    [No Abstract]   [Full Text] [Related]  

  • 10. Toll-free number for reporting adverse events on labeling for human drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Oct; 73(209):63886-97. PubMed ID: 19112682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunization in France: high quality regulation].
    Fuchs F
    Arch Pediatr; 2006 Jun; 13(6):648-50. PubMed ID: 16697585
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vigilance in esthetic dermatology].
    Vigan M
    Ann Dermatol Venereol; 2009 Oct; 136 Suppl 6():S375-80. PubMed ID: 19931701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of adverse drug reactions in a dermatology department.
    Ganeva M; Gancheva T; Lazarova R; Tzvetanova Y; Hristakieva E
    Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):107-12. PubMed ID: 17440627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting adverse events associated with herbal products.
    Decker GM
    Clin J Oncol Nurs; 2000; 4(3):137-8. PubMed ID: 11235252
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of cosmetics: a challenge for dermatology].
    Revuz J; Poli F
    Ann Dermatol Venereol; 1997; 124(4):312-4. PubMed ID: 9739935
    [No Abstract]   [Full Text] [Related]  

  • 16. US creates blame-free adverse event reporting.
    Guthrie P
    CMAJ; 2006 Jan; 174(1):19-20. PubMed ID: 16389225
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug indications and the physician's treatment choice].
    Deutsch E
    Internist (Berl); 1995 Aug; 36(8):837-9. PubMed ID: 7558704
    [No Abstract]   [Full Text] [Related]  

  • 18. The folly of rewarding silence while hoping for open reporting of adverse medical events--how to realign the rewards.
    Chamberlain N
    N Z Med J; 2008 Sep; 121(1282):58-66. PubMed ID: 18815605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research on foreign countries laws and regulations on surveillance and reporting of postmarketing drugs adverse reactions].
    Tian F; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1464-7. PubMed ID: 19771884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral contraceptives in dermatology].
    Sancho B; Guerra-Tapia A
    Actas Dermosifiliogr; 2009; 100(6):445-55. PubMed ID: 19709548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.